In a study of osteosarcoma, LCN2 depletion promoted cell migration and invasion by modulating the MEK-ERK pathway [35], and the MEK inhibitor U0126 significantly decreased osteosarcoma tumor invasion and metastasis in vivo [36]. Here, LCN2 is linked to osteosarcoma.